urnal variation and refractoriness in repeated measures of airways responsiveness to methacholine. Methods -To investigate diurnal variation in airways responsiveness, 24 asthmatic subjects aged 18 -45 underwent five methacholine tests over three days which were not necessarily consecutive: day 1 at 08:00 hours; day 2 at 08:00 hours, 14 :00 hours, 20:00 hours; day 3 at 20:00 hours. To investigate refractoriness a retrospective analysis was undertaken of all paired methacholine tests performed in individuals within our unit between 1984 and 1990 where there had been no intervention likely to affect the results.
Results -The first investigation revealed no diurnal change in airways responsiveness although there was a change in FEV,. Mean PD20 did, however, increase 1-57 fold from 08:00 hours on day 1 to 08:00 hours on day 2 for subjects studied on consecutive days. The second investigation confirmed that a test interval of up to 24 hours (but not of 48 or more hours) was associated with a refractory index (PD20 test 2/PD20 test 1) of >1.
Conclusions -No diurnal variation in airways responsiveness was detected for measurements made between 08:00 hours and 20:00 hours, but an interval between successive tests of up to 24 hours was associated with refractoriness. Diurnal variation is not likely to exert an important confounding effect on methacholine tests carried out between 08:00 hours and 20:00 hours, but confounding could result from refractoriness if tests are repeated at intervals up to 24 hours.
(Thorax 1995;50:235-239) Keywords : methacholine, bronchial hyperreactivity, circadian rhythm, refractory period.
Measurements of airways responsiveness have become widely used in asthma research. They may be used to quantify the beneficial (and adverse) effects ofnovel pharmaceutical agents, and the putative aetiological roles of occupational and environmental exposures. In epidemiological investigations they may provide objective evidence of asthma prevalence.
Diurnal variation in airways responsiveness to histamine and other bronchoconstrictor agents has been described, although its magnitude is said to be relatively small compared with the variation in ventilatory function which is seen in many asthmatics. ' 
MEASUREMENTS OF AIRWAYS RESPONSIVENESS
All data from subjects undergoing two methacholine tests within the previous six years what the maximum extent of diurnal variation might be than in the practical question for epidemiological studies of how much it might influence measurements made at different times during normal working hours. We did not detect any significant change in airways responsiveness during normal waking hours, but there was a progressive (albeit non-significant) increase in PD20 (decrease in airways responsiveness) between 08:00 hours and 20:00 hours consistent with the possibility of diurnal variation. Unexpectedly, there were relatively large differences in PD20 and the dose-response slope between the two 08:00 hours measurements on days 1 and 2, which occurred in the absence of any changes in baseline ventilatory function. For PD20 measurements the magnitude of this difference may have been affected a little by the values given to the censored data, but the dose-response slope data, which were uncensored, also indicated that this was the test interval displaying the greatest mean difference in airways responsiveness. These differences could not have been due to changes in baseline ventilatory function nor to diurnal changes in airways responsiveness, and therefore suggested refractoriness to methacholine. Refractoriness might also have been responsible for the further (though non-significant) sequential increases in PD20 during the second study day. Reanalysis excluding those subjects not tested on consecutive days made the difference between days 1 and 2 at 08:00 hours more apparent, but the differences between all tests on days 2 and 3 remained non-significant.
For the 19 subjects tested on consecutive days it is not clear why a significant degree of refractoriness was not evident also from the 08:00 hours to the 14:00 hours and the 20:00 hours tests on day 2, although there was some hint ofthis. It may be that the effect had already reached (or neared) its maximum, or that the mechanism responsible had in some way fatigued. This could also explain why no evidence of refractoriness was seen between the 20:00 hours tests on days 2 and 3.
The possibility of refractoriness was supported by the review of all previous paired data which confirmed that PD20 measurements repeated after 24 hours (but not after longer periods) were significantly higher than the original measurements. This difference was not large, but was of a similar order of magnitude as that found between the 08:00 hours tests on days 1 and 2 in investigation 1.
Refractoriness to a second methacholine challenge persisting for as long as 24 hours after a first has been described among nonasthmatic subjects with measurable airways responsiveness, but it has not previously been described in asthmatic subjects." Refractoriness to repeated exposures to the other commonly used bronchoconstrictor agonist, histamine, has been described more frequently, although its existence remains disputed by some and its duration has not been established. 2 14 Refractoriness to other bronchoconstrictor agonists has also been described. 1`-8
Refractoriness to histamine develops within an hour of the first exposure and appears to be related to the dose of histamine administered, with some evidence of a threshold dose (and hence PD20) below which it is not observed. '2 14 The previous demonstration ofrefractoriness to methacholine in non-asthmatic subjects (who require large doses ofbronchoconstrictor agonist to establish a PD20) suggests that methacholine refractoriness, as with histamine, might be related to the dose administered." It could therefore be relevant that our test protocol, which records FEV, as the mean of the best three of six FEV1 measurements following each dose of methacholine, generally results in higher doses of methacholine being administered than alternative protocols.8 In the present study, however, there did not seem to be a threshold below which refractoriness did not occur ( figure) .
The physiological basis of refractoriness to methacholine is not clear. Several mechanisms have been postulated including depletion of endogenous mediators, neural reflexes, or the release or production of a "protective" substance preventing or ameliorating a further bronchoconstrictor response; and it may be that refractoriness is the result of a number of different interacting mechanisms.'51819
It seems unlikely that our observations could be due to an artefact or to a learning process in performing spirometric tests. The latter should affect baseline lung function measurements as well as measurements of airways responsiveness, and no significant change in baseline FEV, was detected between the 08:00 hours measurements on days 1 and 2. It is conceivable that subjects might be less cautious about taking deep inhalations during the second and subsequent tests. This might lead both to more peripheral (and less effective) deposition of methacholine, and to some functional antagonism of the bronchoconstrictor effect.202' However, such effects should not be more apparent at 24 hours than after longer time intervals (as observed in investigation 2), and we do not believe either explanation to be very convincing. Dilutions of methacholine were prepared daily from a stock solution kept in a dark glass bottle within a refrigerator at 4°C so there is no possibility of a systematic deterioration in potency during the course of an individual subject's participation in the study."
We also considered whether we had simply observed the phenomenon of "regression to the mean" following selection of hyperresponsive subjects at entry to the study. However, there was no hint of decreasing responsiveness among the five subjects from investigation 1, nor the 72 subjects from investigation 2, who underwent repeated tests on non-consecutive days. For the 72 subjects the mean refractory index (1 -07) was close to 1 and not significantly different from it.
The results ofthis study are ofmost relevance in the design and interpretation of research involving quickly repeated measurements of airways responsiveness using methacholine. Presumed refractoriness to methacholine, although producing only relatively modest changes in PD20 and dose-response slope (of the order of 1 3-1 6 fold at 24 hours), did exert a confounding influence on this study and left us uncertain whether it was the explanation for the progressive increase in PD20 on day 2 or whether there were also diurnal changes in airways responsiveness. Refractoriness might also confound pharmacological studies as it could be interpreted as an effect of treatment. Conversely, refractoriness might reduce the ability to detect increases in airways responsiveness following challenges with aeroallergens or occupational agents. It would therefore seem sensible to ensure that the possibility of prolonged refractoriness to methacholine is taken into account in analyses, or that an appropriate minimum period of 48 hours is allowed between sequential tests.
We cannot exclude the possibility of diurnal variation in measurements of airways responsiveness to methacholine, particularly in subjects showing a prominent diurnal variation in ventilatory function. However, we believe that any change during normal waking (and working) hours is not likely to exert an important confounding effect in epidemiological investigations, and that diurnal variation is of less consequence than refractoriness.
